IRIS UniCatt

Giannarelli, Diana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.508
EU - Europa 935
NA - Nord America 873
SA - Sud America 504
AF - Africa 40
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.868
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 795
SG - Singapore 669
BR - Brasile 417
CN - Cina 394
IT - Italia 393
VN - Vietnam 147
DE - Germania 124
IN - India 75
FR - Francia 68
GB - Regno Unito 59
FI - Finlandia 55
SE - Svezia 49
AR - Argentina 40
KR - Corea 38
IE - Irlanda 36
CA - Canada 34
ID - Indonesia 34
MX - Messico 30
NL - Olanda 29
ES - Italia 28
HK - Hong Kong 28
BD - Bangladesh 25
RU - Federazione Russa 25
EC - Ecuador 20
AT - Austria 17
PL - Polonia 16
ZA - Sudafrica 15
JP - Giappone 14
IQ - Iraq 13
TR - Turchia 12
CO - Colombia 8
MA - Marocco 8
UZ - Uzbekistan 8
PH - Filippine 7
BE - Belgio 6
CZ - Repubblica Ceca 6
IL - Israele 6
KG - Kirghizistan 6
PK - Pakistan 5
SA - Arabia Saudita 5
UA - Ucraina 5
VE - Venezuela 5
CL - Cile 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
LB - Libano 4
LT - Lituania 4
NZ - Nuova Zelanda 4
PE - Perù 4
AL - Albania 3
BG - Bulgaria 3
CR - Costa Rica 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AU - Australia 2
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
EG - Egitto 2
HN - Honduras 2
IR - Iran 2
JO - Giordania 2
OM - Oman 2
RO - Romania 2
TN - Tunisia 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
HU - Ungheria 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
ML - Mali 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.868
Salva come PNG Salva come JPEG
Città #
Singapore 347
Rome 190
Ashburn 168
Hefei 123
Beijing 74
New York 67
Milan 61
Ho Chi Minh City 59
Los Angeles 54
Hyderabad 48
Munich 47
Seoul 38
São Paulo 38
Dallas 37
Dublin 36
Frankfurt am Main 35
Hanoi 35
Kent 32
The Dalles 29
Hong Kong 26
Jakarta 26
Helsinki 22
Turku 18
Nuremberg 17
Lappeenranta 15
Denver 14
Tokyo 14
Buffalo 13
Castelvetrano 13
Guayaquil 13
Mexico City 13
Phoenix 13
Rio de Janeiro 13
Stockholm 13
Brasília 12
Chicago 12
Düsseldorf 12
London 12
Santa Clara 12
Ankara 11
Bexley 11
Montreal 11
Moscow 11
Porto Alegre 11
Warsaw 11
Boardman 10
Brooklyn 10
Poplar 10
Vienna 10
Da Nang 9
Florence 9
Haiphong 9
Johannesburg 9
Bari 8
Belo Horizonte 8
Campinas 8
Maceió 8
Orem 8
Tashkent 8
Toronto 8
Atlanta 7
North Bergen 7
Amsterdam 6
Bishkek 6
Boston 6
Buenos Aires 6
Cattolica 6
Dhaka 6
Mumbai 6
San Francisco 6
Turin 6
Vancouver 6
Biên Hòa 5
Brussels 5
Fortaleza 5
Madrid 5
Olomouc 5
Salvador 5
Shanghai 5
Addis Ababa 4
Baghdad 4
Charlotte 4
Chennai 4
Concepción 4
Council Bluffs 4
Erbil 4
Falkenstein 4
Groningen 4
Houston 4
Hải Dương 4
Islington 4
Jeddah 4
Manchester 4
Naples 4
Querétaro 4
Ribeirão Preto 4
Roubaix 4
Seattle 4
Sorocaba 4
Sumaré 4
Totale 2.212
Salva come PNG Salva come JPEG
Nome #
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 125
Usefulness of differential time to positivity between catheter and peripheral blood cultures for diagnosing catheter-related bloodstream infection: Data analysis from routine clinical practice in the intensive care unit 122
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer 118
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 111
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 109
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 109
Validation of Esaso Classification of Diabetic Maculopathy 98
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 97
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 94
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 93
Quality of life in patients with advanced ovarian cancer after primary debulking surgery versus neoadjuvant chemotherapy: Results from the randomised SCORPION trial (NCT01461850) 92
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 89
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting 86
Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid morphology on ultrasound 86
Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis 85
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria 83
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies 83
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy 83
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed 81
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 81
Real-world outcomes of PARP inhibitor maintenance in advanced ovarian cancer: a focus on disease patterns and treatment modalities at recurrence 79
Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer 79
Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) - A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group 77
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program 74
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 74
Long-Term Safety of Level II Oncoplastic Surgery after Neoadjuvant Treatment for Locally Advanced Breast Cancer: A 20-Year Experience 72
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience 72
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status 69
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model 69
A clinical ultrasound algorithm to identify uterine sarcoma and smooth muscle tumors of uncertain malignant potential in patients with myometrial lesions: the MYometrial Lesion UltrasouNd And mRi study 68
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study) 67
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study 67
Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis 67
Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer 66
Less is more? Comparison between genomic profiling and immunohistochemistry-based models in endometrial cancer molecular classification: A multicenter, retrospective, propensity-matched survival analysis 65
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort 64
Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy 63
Concurrent endometrial cancer in atypical endometrial hyperplasia and the role of sentinel lymph nodes: clinical insights from a multicenter experience 61
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 59
Optimizing patient selection for secondary cytoreductive surgery in recurrent endometrial cancer 59
STOMA study SToma-leak ratio in advanced ovarian cancer surgery: Results of a restrictive policy on the use of protective stoMAs 58
Lymph node staging in grade 1–2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth? 58
The new surgical robot Hugo™ RAS for total hysterectomy: a pilot study 57
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 57
Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese) 54
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study 54
Flurbiprofen in the subglottic space to prevent postoperative sore throat after cardiac surgery: A randomized double-blind study 52
Prevalence of diabetes and diabetic macular edema in patients undergoing senile cataract surgery in Italy: The DIabetes and CATaract study 49
Protocol for an international multicenter, prospective, observational, non-competitive, study to validate and optimise prediction models of 90-day and 1-year allograft failure after liver transplantation: The global IMPROVEMENT Study 46
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 41
Secondary analyses from a randomized clinical trial: Age as the key prognostic factor in endometrial carcinoma 36
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study 29
Minimally invasive simple hysterectomy in low-risk cervical cancer: a single-arm trial with stopping rules (ENGOT-cx23/MITO/LASH trial) 16
Familial forms of chronic lymphocytic leukemia have a worse prognosis than sporadic forms: an Italian case-control study 15
Richter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes 13
Microscopic assessment of lymph node status in gynecological malignancies using full-field optical coherence tomography 8
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer 3
Totale 3.942
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.892
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202370 0 0 0 0 0 1 2 13 4 2 16 32
2023/2024373 9 48 51 23 21 53 26 7 7 25 53 50
2024/20251.297 25 10 53 46 58 45 66 37 95 169 370 323
2025/20262.202 411 240 326 618 541 66 0 0 0 0 0 0
Totale 3.942